Literature DB >> 16731944

Human leukocyte antigen B58 supertype and human immunodeficiency virus type 1 infection in native Africans.

Aleksandr Lazaryan1, Elena Lobashevsky, Joseph Mulenga, Etienne Karita, Susan Allen, Jianming Tang, Richard A Kaslow.   

Abstract

Human leukocyte antigen (HLA) class I alleles can be grouped into supertypes according to their shared peptide binding properties. We examined alleles of the HLA-B58 supertype (B58s) in treatment-naïve human immunodeficiency virus type 1 (HIV-1)-seropositive Africans (423 Zambians and 202 Rwandans). HLA-B and HLA-C alleles were resolved to four digits by a combination of molecular methods, and their respective associations with outcomes of HIV-1 infection were analyzed by statistical procedures appropriate for continuous or categorical data. The effects of the individual alleles on natural HIV-1 infection were heterogeneous. In HIV-1 subtype C-infected Zambians, the mean viral load (VL) was lower among B*5703 (P = 0.01) or B*5703-Cw*18 (P < 0.001) haplotype carriers and higher among B*5802 (P = 0.02) or B*5802-Cw*0602 (P = 0.03) carriers. The B*5801-Cw*03 haplotype showed an association with low VL (P = 0.05), whereas B*5801 as a whole did not. Rwandans with HIV-1 subtype A infection showed associations of B*5703 and B*5802 with slow (P = 0.06) and rapid (P = 0.003) disease progression, respectively. In neither population were B*1516-B*1517 alleles associated with more favorable responses. Overall, B58s alleles, individually or as part of an HLA-B-HLA-C haplotype, appeared to have a distinctive impact on HIV-1 infection among native Africans. As presently defined, B58s alleles cannot be considered uniformly protective against HIV/AIDS in every population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16731944      PMCID: PMC1472610          DOI: 10.1128/JVI.02119-05

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes.

Authors:  J Longmate; J York; C La Rosa; R Krishnan; M Zhang; D Senitzer; D J Diamond
Journal:  Immunogenetics       Date:  2001       Impact factor: 2.846

2.  AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis.

Authors:  Xiaojiang Gao; Arman Bashirova; Astrid K N Iversen; John Phair; James J Goedert; Susan Buchbinder; Keith Hoots; David Vlahov; Marcus Altfeld; Stephen J O'Brien; Mary Carrington
Journal:  Nat Med       Date:  2005-11-20       Impact factor: 53.440

3.  Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

Authors:  Photini Kiepiela; Alasdair J Leslie; Isobella Honeyborne; Danni Ramduth; Christina Thobakgale; Senica Chetty; Prinisha Rathnavalu; Corey Moore; Katja J Pfafferott; Louise Hilton; Peter Zimbwa; Sarah Moore; Todd Allen; Christian Brander; Marylyn M Addo; Marcus Altfeld; Ian James; Simon Mallal; Michael Bunce; Linda D Barber; James Szinger; Cheryl Day; Paul Klenerman; James Mullins; Bette Korber; Hoosen M Coovadia; Bruce D Walker; Philip J R Goulder
Journal:  Nature       Date:  2004-12-09       Impact factor: 49.962

4.  Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa.

Authors:  S A Allen; R Musonda; S Trask; B H Hahn; H Weiss; J Mulenga; F Kasolo; S H Vermund; G M Aldrovandi
Journal:  AIDS Res Hum Retroviruses       Date:  2001-07-01       Impact factor: 2.205

5.  Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 infection in a Zambian population.

Authors:  A López-Vázquez; A Miña-Blanco; J Martínez-Borra; P D Njobvu; B Suárez-Alvarez; M A Blanco-Gelaz; S González; L Rodrigo; C López-Larrea
Journal:  Hum Immunol       Date:  2005-03       Impact factor: 2.850

6.  HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load.

Authors:  Nicole Frahm; Sharon Adams; Photini Kiepiela; Caitlyn H Linde; Hannah S Hewitt; Mathias Lichterfeld; Kaori Sango; Nancy V Brown; Eunice Pae; Alysse G Wurcel; Marcus Altfeld; Margaret E Feeney; Todd M Allen; Timothy Roach; M Anne St John; Eric S Daar; Eric Rosenberg; Bette Korber; Francesco Marincola; Bruce D Walker; Philip J R Goulder; Christian Brander
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

7.  Identification of most frequent HLA class I antigen specificities in Botswana: relevance for HIV vaccine design.

Authors:  V Novitsky; P O Flores-Villanueva; P Chigwedere; S Gaolekwe; H Bussman; G Sebetso; R Marlink; E J Yunis; M Essex
Journal:  Hum Immunol       Date:  2001-02       Impact factor: 2.850

8.  Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design.

Authors:  V Novitsky; N Rybak; M F McLane; P Gilbert; P Chigwedere; I Klein; S Gaolekwe; S Y Chang; T Peter; I Thior; T Ndung'u; F Vannberg; B T Foley; R Marlink; T H Lee; M Essex
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 9.  HIV vaccines: where we are and where we are going.

Authors:  B F Haynes
Journal:  Lancet       Date:  1996-10-05       Impact factor: 79.321

10.  Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression.

Authors:  Guillaume B E Stewart-Jones; Geraldine Gillespie; Ian M Overton; Rupert Kaul; Philippe Roche; Andrew J McMichael; Sarah Rowland-Jones; E Yvonne Jones
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

View more
  32 in total

1.  Dynamics and Correlates of CD8 T-Cell Counts in Africans with Primary Human Immunodeficiency Virus Type 1 Infection.

Authors:  Heather A Prentice; Hailin Lu; Matthew A Price; Anatoli Kamali; Etienne Karita; Shabir Lakhi; Eduard J Sanders; Omu Anzala; Susan Allen; Paul A Goepfert; Eric Hunter; Jill Gilmour; Jianming Tang
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

2.  Clade-specific evolution mediated by HLA-B*57/5801 in human immunodeficiency virus type 1 clade A1 p24.

Authors:  Lyle R McKinnon; Rupert Capina; Harold Peters; Mark Mendoza; Joshua Kimani; Charles Wachihi; Anthony Kariri; Makobu Kimani; Meika Richmond; Sandy Koesters Kiazyk; Keith R Fowke; Walter Jaoko; Ma Luo; T Blake Ball; Francis A Plummer
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

3.  High-dimensional immunomonitoring models of HIV-1-specific CD8 T-cell responses accurately identify subjects achieving spontaneous viral control.

Authors:  Zaza M Ndhlovu; Lori B Chibnik; Jacqueline Proudfoot; Seanna Vine; Ashley McMullen; Kevin Cesa; Filippos Porichis; R Brad Jones; Donna Marie Alvino; Meghan G Hart; Eleni Stampouloglou; Alicja Piechocka-Trocha; Carl Kadie; Florencia Pereyra; David Heckerman; Philip L De Jager; Bruce D Walker; Daniel E Kaufmann
Journal:  Blood       Date:  2012-12-11       Impact factor: 22.113

4.  HLA class I-mediated control of HIV-1 in the Japanese population, in which the protective HLA-B*57 and HLA-B*27 alleles are absent.

Authors:  Takuya Naruto; Hiroyuki Gatanaga; George Nelson; Keiko Sakai; Mary Carrington; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

5.  Immunogenetic factors in early immune control of human immunodeficiency virus type 1 (HIV-1) infection: Evaluation of HLA class I amino acid variants in two African populations.

Authors:  Howard W Wiener; Sadeep Shrestha; Hailin Lu; Etienne Karita; William Kilembe; Susan Allen; Eric Hunter; Paul A Goepfert; Jianming Tang
Journal:  Hum Immunol       Date:  2017-12-28       Impact factor: 2.850

6.  The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans.

Authors:  Aleksandr Lazaryan; Wei Song; Elena Lobashevsky; Jianming Tang; Sadeep Shrestha; Kui Zhang; Janet M McNicholl; Lytt I Gardner; Craig M Wilson; Robert S Klein; Anne Rompalo; Kenneth Mayer; Jack Sobel; Richard A Kaslow
Journal:  Hum Immunol       Date:  2011-01-21       Impact factor: 2.850

7.  HIV-1 evolution following transmission to an HLA-B*5801-positive patient.

Authors:  Karen A O'Connell; Jie Xu; Anna P Durbin; Linda G Apuzzo; Hejab Imteyaz; Thomas M Williams; Stuart C Ray; Joseph B Margolick; Robert F Siliciano; Joel N Blankson
Journal:  J Infect Dis       Date:  2009-12-15       Impact factor: 5.226

8.  Human leukocyte antigens and HIV type 1 viral load in early and chronic infection: predominance of evolving relationships.

Authors:  Jianming Tang; Rakhi Malhotra; Wei Song; Ilene Brill; Liangyuan Hu; Paul K Farmer; Joseph Mulenga; Susan Allen; Eric Hunter; Richard A Kaslow
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

9.  Human leukocyte antigen class I genotypes in relation to heterosexual HIV type 1 transmission within discordant couples.

Authors:  Jianming Tang; Wenshuo Shao; Yun Joo Yoo; Ilene Brill; Joseph Mulenga; Susan Allen; Eric Hunter; Richard A Kaslow
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

10.  Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients.

Authors:  Hayley Crawford; Wendy Lumm; Alasdair Leslie; Malinda Schaefer; Debrah Boeras; Julia G Prado; Jianming Tang; Paul Farmer; Thumbi Ndung'u; Shabir Lakhi; Jill Gilmour; Paul Goepfert; Bruce D Walker; Richard Kaslow; Joseph Mulenga; Susan Allen; Philip J R Goulder; Eric Hunter
Journal:  J Exp Med       Date:  2009-03-23       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.